Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCLE: Immune Reconstitution After Letermovir Prophylaxis in HSCT
NCT07915505Completed
- Sponsor
- CHU de Limoges
- Start
- Sep 2022
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Open-label trial of letermovir in cytomegalovirus infection (CMV) (2 arms), sponsored by CHU de Limoges. Primary endpoints: Viral load of torque teno virus (TTV) in whole blood at Month 12, Qualitative and functional assessment of natural killer (NK) cells at Day 100 and 5 more. Started Sep 2022; status: completed.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07915505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07915505.